About MZY BIO

A clear record of our company identity, scientific focus and operating structure.

MZY BIO (also written as MZYBIO) is the international brand operated by Anqing Sijimingfu Pet Co., Ltd. We focus on pet cloning consultation, animal somatic-cell preservation and genetic-resource preservation, with an emphasis on responsible and transparent communication.

Life-science laboratory team working beside equipment

Company Profile

A concise record of legal identity, location, core scope, and documented focus.

Brand name
MZY BIO
Chinese legal entity
安庆四季鸣福宠物有限公司
Operating company (English)
Anqing Sijimingfu Pet Co., Ltd.
Location
Anqing, Anhui, China
Subsidiary
济南缪志远生物科技有限公司
Subsidiary location
Huaiyin District, Jinan, Shandong, China
Subsidiary registered capital
RMB 5 million
Core scope
Pet cloning consultation, animal somatic cell preservation, genetic resource preservation, and conservation breeding-related life-science services
Focus since 2020
Focused on pet cloning and animal genetic-resource preservation since 2020

Documented Timeline

Only dates with sufficient public evidence are included.

  1. A documented focus begins

    MZY BIO began its continuing focus on pet cloning and animal genetic-resource preservation.

What We Do

Through the MZY BIO brand, Anqing Sijimingfu Pet Co., Ltd. provides consultation and life-science services related to pet cloning, animal somatic cell preservation, and genetic resource preservation.

  • Support consultations about pet cloning and project fit.
  • Discuss sample, somatic cell, and genetic-resource preservation pathways.
  • Explain scientific principles and project boundaries before commercial decisions.
  • Support international client consultation and coordination without implying route availability.

What We Do Not Claim

Trust requires stating what a company does not promise.

  • We do not claim that cloning reproduces memory.
  • We do not claim that cloning reproduces personality or lived experience.
  • We do not promise that every sample can establish usable cells.
  • We do not publish cases without authorization and factual review.
  • We do not publish unsupported success rates or guaranteed outcomes.

Research Collaboration

Partner names, agreements, and collaboration imagery are published only after documentary and authorization review.

Responsible Communication

Scientific principles, company evidence, commercial information, and confidential project records are kept distinct.

Evidence before claims

Company facts are published only at the level that can be supported.

Science separated from results

General scientific references do not stand in for project evidence.

Confidentiality by default

Client records, samples, procedures, and sensitive parameters remain private.

How an international inquiry begins

The journey organizes information and decisions; it does not promise that collection or transport is available for every location.

Information to provide at the start

  • Country or region
  • Animal species
  • Current status
  • Whether a sample already exists
  • Service need
  • Contact language
  • Urgency
  • Privacy consent
  1. Information required

    International Client Entry

    Provide the minimum facts needed to understand the situation.

  2. Under preliminary review

    Situation Triage

    Urgency, animal condition, and existing material are reviewed first.

  3. Under preliminary review

    Preliminary Fit Review

    The team identifies what can be assessed and what information is still missing.

  4. Collection planning

    Local Collection Coordination

    Any professional collection requirement is discussed for the local context.

  5. Route feasibility review

    International Route Review

    Transport, quarantine, timing, and destination requirements are reviewed case by case.

  6. Laboratory evaluation

    Receipt and Laboratory Decision

    Receipt is recorded before laboratory observations inform the next decision.